UPV-EHU ADDI
  • Back
    • English
    • Español
    • Euskera
  • Login
  • English 
    • English
    • Español
    • Euskera
  • FAQ
View Item 
  •   Home
  • INVESTIGACIÓN
  • Artículos, Comunicaciones, Libros
  • Artículos
  • View Item
  •   Home
  • INVESTIGACIÓN
  • Artículos, Comunicaciones, Libros
  • Artículos
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals

Thumbnail
View/Open
journal.pone.0095022.pdf (554.4Kb)
Date
2014-04-17
Author
Abulí, Anna
Bujanda Fernández de Pierola, Luis
Mun, Jenifer
Buch, Stephan
Schafmayer, Clemens
Maiorana, Maria Valeria
Veneroni, Silvia
Van Wezel, Tom
Liu, Tao
Westers, Helga
Esteban-Jurado, Clara
Ocan, Teresa
Pique, Josep M.
Andreu, Montserrat
Jover, Rodrigo
Carracedo, Angel
Xicola, Rosa M.
Llor, Xavier
Castells, Antoni
The EPICOLON Consortium
Dunlop15, Malcolm
Hofstra, Robert
Lindblom, Annika
Wijnen, Juul
Peterlongo, Paolo
Hampe, Jochen
Ruiz- Ponte, Clara
Castellví-Bel, Sergi
Metadata
Show full item record
PLOS ONE 9(4) : (2014) // Article ID e95022
URI
http://hdl.handle.net/10810/17094
Abstract
Colorectal cancer is one of the most frequent neoplasms and an important cause of mortality in the developed world. Mendelian syndromes account for about 5% of the total burden of CRC, being Lynch syndrome and familial adenomatous polyposis the most common forms. Lynch syndrome tumors develop mainly as a consequence of defective DNA mismatch repair associated with germline mutations in MLH1, MSH2, MSH6 and PMS2. A significant proportion of variants identified by screening these genes correspond to missense or noncoding changes without a clear pathogenic consequence, and they are designated as "variants of uncertain significance'', being the c.1852_1853delinsGC (p.K618A) variant in the MLH1 gene a clear example. The implication of this variant as a low-penetrance risk variant for CRC was assessed in the present study by performing a case-control study within a large cohort from the COGENT consortium-COST Action BM1206 including 18,723 individuals (8,055 colorectal cancer cases and 10,668 controls) and a case-only genotype-phenotype correlation with several clinical and pathological characteristics restricted to the Epicolon cohort. Our results showed no involvement of this variant as a low-penetrance variant for colorectal cancer genetic susceptibility and no association with any clinical and pathological characteristics including family history for this neoplasm or Lynch syndrome.
Collections
  • Artículos
  • OpenAire

DSpace software copyright © 2002-2015  DuraSpace
OpenAIRE
OpenAIRE
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesDepartamentos (cas.)Departamentos (eus.)SubjectsThis CollectionBy Issue DateAuthorsTitlesDepartamentos (cas.)Departamentos (eus.)Subjects

My Account

Login

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
OpenAIRE
OpenAIRE